acetovanillone: Clinical Trials

5 trials of acetovanillone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5

Follow acetovanillone: new trials by email Literature Review of acetovanillone trials Research Report on acetovanillone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Local Antioxidant Therapy on Racial Differences in Vasoconstriction
Control (Phenylephrine), Phenylephrine + Apocynin, Phenylephrine + Allopurinol - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington242018-10-012020-11-05
The Effect of Antioxidants on Skin Blood Flow-BH4
Control: Lacated Ringers, Apocynin, Allopurinol - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington162018-01-082018-09-26
The Effect of Antioxidants on Skin Blood Flow During Local Heating
Control (Lactated Ringer's), Tempol, Apocynin - Cardiovascular Diseases, Cardiovascular Risk Factor
Phase 1CompletedThe University of Texas at Arlington442016-09-072018-09-21
Hydrogen Peroxide and Nitrite Reduction in Exhaled Breath Condensate of COPD Patients
Apocynin and placebo nebulization - Chronic Obstructive Pulmonary Disease
Phase 1CompletedMedical University of Lodz132010-10-012011-07-26
Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics
Apocynin nebulization - Bronchial Asthma
Phase 1CompletedMedical University of Lodz102008-06-012009-10-09

Conditions studied

Cardiovascular Diseases (3)  ·  Aneurysm (1)  ·  Asthma (1)  ·  Obesity (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

The University of Texas at Arlington (3)  ·  Medical University of Lodz (2)

Countries

United States (3)  ·  Poland (1)

Top investigators

Rafal Pawliczak, MD, PhD (1)  ·  Rafal Pawliczak, Professor (1)

Results publications

PMID 11163535, PMID 11728816, PMID 33515429